Frontiers in Pharmacology

Frontiers in Pharmacology is an interdisciplinary journal that publishes research on the interactions between drugs and living beings to prevent and cure human disease. Led by Field Chief Editor Heike Wulff (University of California, Davis, US), Frontiers in Pharmacology explores basic and clinical pharmacology, medicinal chemistry, pharmacy, and toxicology to clarify the fundamental processes of disease treatment and drug effects. Indexed in PubMed Central (PMC), Scopus, Web of Science (SCIE), and the DOAJ, the journal welcomes academic, industrial, and clinical work focused on pharmacology., , Topics include, but are not limited to: cardiovascular and smooth muscle pharmacology, drug metabolism and transport, drugs outcomes research and policies, ELSI in science and genetics, ethnopharmacology, experimental pharmacology and drug discovery, gastrointestinal and hepatic pharmacology, inflammation pharmacology, integrative and regenerative pharmacology, neuropharmacology, obstetric and pediatric pharmacology, pharmacoepidemiology, pharmacogenetics and pharmacogenomics, pharmacology of anti-cancer drugs, pharmacology of infectious diseases, pharmacology of ion channels and channelopathies, predictive toxicology, renal pharmacology, respiratory pharmacology, translational pharmacology., All submissions to the journal Frontiers in Pharmacology involving natural products, including plant extracts or preparations must adhere to “The Four Pillars of Ethnopharmacology” to be considered for peer review, regardless of the specialty section, as a baseline standard for sample characterization. To be considered for publication in Frontiers in Pharmacology, studies incorporating complementary or alternative medicine must be based on a set of data linked to local or traditional uses that can be evaluated pharmacologically. A clear and plausible set of pharmacological data must be generated in these studies. Similarly, the journal endorses protocols including a minimum of 2 cell-lines in vitro as an evidential basis to demonstrate proposed anti-cancer effects in all relevant studies submitted to all specialty sections in the journal.,